Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02061813 · ClinicalTrials.gov registry record · Phase 1
Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion
A Phase 1 study, sponsored by Dr. Reddy's Laboratories Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
NCT02061813 is a Phase 1 study that has completed, run by Dr. Reddy's Laboratories Limited. The registered enrollment target is 40 participants.
The verdict
NCT02061813, a Phase 1 study, has completed, sponsored by Dr. Reddy's Laboratories Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.
Interventions
- DRUG Placebo
- DRUG Saline 0.9%
- DRUG Abametapir Lotion 0.74% w/w
- DRUG Sodium Lauryl Sulfate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-01 |
| Est. Completion | 2014-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02061813
The ClinicalTrials.gov registry entry for NCT02061813 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dr. Reddy's Laboratories Limited, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02061813 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02061813 about?
NCT02061813 is a clinical study titled "Dermal Safety Study to Evaluate Potential Irritation of Abametapir Lotion". The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.
What is the current status of trial NCT02061813?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2014-01. Estimated completion is 2014-05.
What interventions are being tested in trial NCT02061813?
The interventions under investigation include: Placebo (DRUG), Saline 0.9% (DRUG), Abametapir Lotion 0.74% w/w (DRUG), Sodium Lauryl Sulfate (DRUG).
Who is sponsoring clinical trial NCT02061813?
This trial is sponsored by Dr. Reddy's Laboratories Limited, which has 52 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.